DarioHealth (DRIO) to Release Earnings on Thursday

DarioHealth (NASDAQ:DRIO) is expected to release its earnings data before the market opens on Thursday, March 27th. Analysts expect DarioHealth to post earnings of ($0.24) per share and revenue of $7.39 million for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

DarioHealth Stock Performance

NASDAQ:DRIO opened at $0.66 on Wednesday. The stock’s 50-day moving average is $0.68 and its 200-day moving average is $0.81. DarioHealth has a 1-year low of $0.56 and a 1-year high of $1.93. The company has a current ratio of 1.57, a quick ratio of 1.32 and a debt-to-equity ratio of 0.35. The stock has a market cap of $27.59 million, a P/E ratio of -0.71 and a beta of 1.42.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. Stifel Nicolaus dropped their price target on shares of DarioHealth from $3.50 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, March 11th. TD Cowen downgraded DarioHealth from a “buy” rating to a “hold” rating and cut their target price for the stock from $2.00 to $1.00 in a report on Wednesday, January 29th.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.